Kynam Capital Management, LP 2seventy Bio, Inc. Transaction History
Kynam Capital Management, LP
- $1.58 Billion
- Q4 2024
A detailed history of Kynam Capital Management, LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,953,825 shares of TSVT stock, worth $16.7 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
5,953,825
Previous 5,953,825
-0.0%
Holding current value
$16.7 Million
Previous $28.1 Million
37.71%
% of portfolio
1.11%
Previous 2.31%
Shares
3 transactions
Others Institutions Holding TSVT
# of Institutions
127Shares Held
44.8MCall Options Held
17.3KPut Options Held
2.9K-
Goldman Sachs Group Inc New York, NY4.29MShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$10.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$10.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$8.17 Million0.0% of portfolio
-
Newtyn Management, LLC New York, NY2.53MShares$7.1 Million1.51% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $106M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...